Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
According to the complaint, despite Delta Pharma’s repeated promises to correct deficiencies, Delta Pharma continued to violate the law.
read more
U.S. District Judge Robert J. Shelby entered a consent decree of permanent injunction between the U.S. and Isomeric Pharmacy Solutions, two of the company’s co-owners and COO.
read more
U.S. District Judge Kristine G. Baker for the Eastern District of Arkansas entered a consent decree of permanent injunction today between the U.S. and Cantrell Drug Company of Little Rock, Arkansas, and the company’s Chief Executive Officer and co-...
read more
The Feinstein Institutes for Medical Research has joined a national network formed by Mayo Clinic to collect convalescent plasma from patients previously identified with COVID-19, but no longer symptomatic.
read more
Monday, November 17, 2014
Felicitex Therapeutics, a leader in the diagnostics and development of therapeutics for quiescent cancers, and Selvita (PL: SLV), the largest drug discovery company in Central and Eastern Europe, announced today that they have entered into a ...
read more
Thursday, January 22, 2015
FEops, a pioneer in the field of patient-specific 3D simulations for cardiovascular interventions, is pleased to announce the closing of a €1.3 million series A financing round, led by Capricorn Venture Partners and PMV. The funding will be used to ...
read more
Ferring Pharmaceuticals and Alrise Biosystems announced that the companies have entered into a development agreement with exclusive option rights for Ferring to leverage Alrise’s ImSus®Technology Platform for the development of an injectable, ...
read more
Monday, February 13, 2017
Ferring Pharmaceuticals and Foresee Pharmaceuticals have entered into an exclusive worldwide development and option agreement to leverage Foresee’s proprietary and unique Stabilized Injectable Formulation platform (SIF) for the development of long ...
read more
Fette Compacting and CMIC CMO USA have announced a new partnership focused on pharmaceutical manufacturing technology. The collaboration involves integrating Fette Compacting’s FE CPS Continuous Direct Compression system and the FE55 rotary tablet ...
read more
Wednesday, April 08, 2020
FFF Enterprises announced its decision to expand its supply of essential medications to support and equip healthcare providers in their battle against COVID-19.
read more
Monday, December 02, 2019
FGK Clinical Research GmbH (FGK) has entered into a multi-year partnership with OmniComm Systems.
read more
Thursday, December 02, 2021
FHI Clinical Inc. announced its intent to acquire Triclinium Clinical Development Proprietary Limited (TCD), a full-service, South African-based CRO and a subsidiary of EOH, one of the largest technology services companies in Africa. With this ...
read more
Tuesday, September 12, 2023
FibroBiologics, a clinical-stage biotechnology company focused on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced the dedication of its cutting-edge laboratory ...
read more
Wednesday, April 17, 2019
Fibrocell announced a collaboration agreement with Castle Creek to develop and commercialize FCX-007 for the treatment of recessive dystrophic epidermolysis bullosa (RDEB).
read more
FibroGenesis has entered into a manufacturing agreement with iBiologics to supply its proprietary allogeneic fibroblast cells to support FibroGenesis's growing chronic disease platform and ongoing clinical trials.
read more